INT221508

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.79
First Reported 2007
Last Reported 2011
Negated 3
Speculated 0
Reported most in Body
Documents 14
Total Number 19
Disease Relevance 8.97
Pain Relevance 0.77

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
lungs 1
IFN1@ (Homo sapiens)
Pain Link Frequency Relevance Heat
cytokine 217 94.96 High High
anesthesia 5 78.32 Quite High
Inflammation 42 66.48 Quite High
antagonist 2 65.28 Quite High
Pain 11 23.12 Low Low
Crohn's disease 25 5.00 Very Low Very Low Very Low
Potency 17 5.00 Very Low Very Low Very Low
headache 7 5.00 Very Low Very Low Very Low
dexamethasone 6 5.00 Very Low Very Low Very Low
alcohol 5 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 126 99.92 Very High Very High Very High
Mycobacterial Infection 208 99.74 Very High Very High Very High
Renal Cancer 378 98.40 Very High Very High Very High
Hypertension 72 97.68 Very High Very High Very High
Granuloma 3 97.52 Very High Very High Very High
Leishmaniasis 33 97.12 Very High Very High Very High
Hemorrhage 19 96.96 Very High Very High Very High
Apoptosis 3 96.88 Very High Very High Very High
Ebola Virus Infection 110 96.64 Very High Very High Very High
Carcinoma 55 96.64 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The limit of quantitation of IFN-?
Phosphorylation (quantitation) of IFN
1) Confidence 0.79 Published 2007 Journal J Transl Med Section Body Doc Link PMC2217514 Disease Relevance 0.36 Pain Relevance 0.03
The data from this latter study supported the approval of bevacizumab plus IFN-?
Phosphorylation (bevacizumab) of IFN
2) Confidence 0.79 Published 2010 Journal Cancer management and research Section Body Doc Link PMC3004565 Disease Relevance 0.51 Pain Relevance 0
The dose of IFN-?
Phosphorylation (dose) of IFN
3) Confidence 0.79 Published 2010 Journal Cancer management and research Section Body Doc Link PMC3004565 Disease Relevance 0.74 Pain Relevance 0
Also, in view of the recognized lack of IFN-?
Neg (lack) Phosphorylation (lack) of IFN
4) Confidence 0.79 Published 2010 Journal Cancer management and research Section Body Doc Link PMC3004565 Disease Relevance 0.56 Pain Relevance 0.04
The activity of bevacizumab plus IFN-?
Phosphorylation (bevacizumab) of IFN
5) Confidence 0.79 Published 2010 Journal Cancer management and research Section Body Doc Link PMC3004565 Disease Relevance 0.47 Pain Relevance 0.05
In view of the recognized lack of IFN-?
Neg (lack) Phosphorylation (lack) of IFN
6) Confidence 0.79 Published 2010 Journal Cancer management and research Section Body Doc Link PMC3004565 Disease Relevance 0.27 Pain Relevance 0
Consequently, the ratio of IFN-?
Phosphorylation (ratio) of IFN
7) Confidence 0.79 Published 2011 Journal Evidence-based Complementary and Alternative Medicine : eCAM Section Body Doc Link PMC2958556 Disease Relevance 0.54 Pain Relevance 0
Lack of IFN-?
Neg (Lack) Phosphorylation (Lack) of IFN
8) Confidence 0.79 Published 2010 Journal PLoS Neglected Tropical Diseases Section Body Doc Link PMC2910702 Disease Relevance 0.73 Pain Relevance 0.19
The large increase in the frequency of IFN-?
Phosphorylation (frequency) of IFN
9) Confidence 0.79 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2882341 Disease Relevance 0.07 Pain Relevance 0.08
Similar to that observed with serum antibody responses, the number of IFN-?
Phosphorylation (number) of IFN
10) Confidence 0.79 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2882341 Disease Relevance 0.17 Pain Relevance 0.03
Immunohistochemistry of Mtb-laden lungs show increased IFN-?
Phosphorylation (show) of IFN in lungs associated with mycobacterial infection
11) Confidence 0.79 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2737621 Disease Relevance 0.88 Pain Relevance 0.11
The numbers of IL-4 and IFN-?
Phosphorylation (numbers) of IFN
12) Confidence 0.79 Published 2009 Journal Reprod Biol Endocrinol Section Body Doc Link PMC2695819 Disease Relevance 0 Pain Relevance 0.08
R) as well as the differential ability of IFN-?
Phosphorylation (ability) of IFN
13) Confidence 0.79 Published 2008 Journal Arthritis Res Ther Section Body Doc Link PMC2575631 Disease Relevance 0.07 Pain Relevance 0.08
In parallel, the level of IFN?
Phosphorylation (level) of IFN
14) Confidence 0.79 Published 2008 Journal Arthritis Res Ther Section Body Doc Link PMC2575631 Disease Relevance 0.05 Pain Relevance 0
The frequency of IFN-?
Phosphorylation (frequency) of IFN
15) Confidence 0.79 Published 2008 Journal PLoS ONE Section Abstract Doc Link PMC2569416 Disease Relevance 0.32 Pain Relevance 0
Pre-existing immunity did not compromise the frequency of IFN-?
Phosphorylation (frequency) of IFN
16) Confidence 0.79 Published 2008 Journal PLoS ONE Section Abstract Doc Link PMC2569416 Disease Relevance 0.34 Pain Relevance 0
In contrast, we noticed a modest decrease in the number of PP CXCR3+, IFN-?
Phosphorylation (number) of IFN
17) Confidence 0.79 Published 2008 Journal BMC Immunol Section Body Doc Link PMC2443107 Disease Relevance 0.65 Pain Relevance 0.07
Also the concentrations of IFN-?
Phosphorylation (concentrations) of IFN
18) Confidence 0.79 Published 2008 Journal BMC Infect Dis Section Body Doc Link PMC2279134 Disease Relevance 1.68 Pain Relevance 0
The data from this latter study supported the approval of bevacizumab plus IFN-?
Phosphorylation (approval) of IFN
19) Confidence 0.79 Published 2010 Journal Cancer management and research Section Body Doc Link PMC3004565 Disease Relevance 0.56 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox